HYPOGONADISM FEMALE

This adverse event was reported 17 times

HYPOGONADISM FEMALE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 THIOTEPA 8 0.0008
1 MELPHALAN HYDROCHLORIDE 7 0.0003
2 MITOXANTRONE HYDROCHLORIDE 1 0.0002
3 DIVALPROEX SODIUM 1 0.0000
4 DENOSUMAB 4 0.0000
5 ERENUMAB-AOOE 1 0.0000
6 CYTARABINE 1 0.0000
7 CARBAMAZEPINE 1 0.0000
8 ETOPOSIDE 1 0.0000
9 CYCLOPHOSPHAMIDE FOR INJECTION 2 0.0000
See all drugs enriched for association with HYPOGONADISM FEMALE

HYPOGONADISM FEMALE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Alkylating Drug [EPC] 10 0.0000
1 RANK Ligand Inhibitor [EPC] 4 0.0000
2 Topoisomerase Inhibitor [EPC] 1 0.0000
3 Mood Stabilizer [EPC] 1 0.0000
4 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
5 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
6 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with HYPOGONADISM FEMALE